(Q35621776)

9 August 2017

1 reference

title

HLA-G and IL-10 expression in human cancer--different stories with the same message (English)

1 reference

9 August 2017

Mirjana Urosevic

1 reference

9 August 2017

Reinhard Dummer

series ordinal

1 reference

9 August 2017

publication date

1 October 2003

1 reference

Seminars in Cancer Biology

9 August 2017

published in

1 reference

9 August 2017

1 reference

9 August 2017

1 reference

9 August 2017

page(s)

337-342

1 reference

Natural selection of tumor variants in the generation of "tumor escape" phenotypes

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

Cytokines and immune response in the tumor microenvironment

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

HLA class I antigen abnormalities and immune escape by malignant cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

HLA-G and MIC expression in tumors and their role in anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

In search of the 'missing self': MHC molecules and NK cell recognition

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

NK cell recognition of non-classical HLA class I molecules

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

Cancer immunoediting: from immunosurveillance to tumor escape

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

Selective MHC expression in tumours modulates adaptive and innate antitumour responses

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

HLA-G: a tolerance molecule from the major histocompatibility complex

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

The immunotolerance role of HLA-G.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors?

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

A soluble HLA-G protein that inhibits natural killer cell-mediated cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

Soluble human MHC class I molecules induce soluble Fas ligand secretion and trigger apoptosis in activated CD8(+) Fas (CD95)(+) T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

HLA-G suppresses proliferation of CD4(+) T-lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

HLA-G inhibits the allogeneic proliferative response

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

Expression analysis of classic and non-classic HLA molecules before interferon alfa-2b treatment of melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

HLA-G protein up-regulation in primary cutaneous lymphomas is associated with interleukin-10 expression in large cell T-cell lymphomas and indolent B-cell lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

Altered pattern of major histocompatibility complex expression in renal carcinoma: tumor-specific expression of the nonclassical human leukocyte antigen-G molecule is restricted to clear cell carcinoma while up-regulation of other major histocompati

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

HLA-G protein expression is not induced during malignant transformation.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

Soluble human leukocyte antigen--G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

DNA methylation in cancer: too much, but also too little

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

HLA-G gene repression is reversed by demethylation

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

Analysis of HLA-G expression in tumor cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

Analysis of HLA-G expression in breast cancer tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

Expression of HLA G in human tumors is not a frequent event.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-I, HLA class-II and ICAM-1 molecules

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

Immune stimulatory potential of B7.1 and B7.2 retrovirally transduced melanoma cells: suppression by interleukin 10.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

Interleukin-10 inhibits the immune stimulatory potential of melanoma cells retrovirally transduced with human B7.1 or B7.2.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

Human placental cytotrophoblasts produce the immunosuppressive cytokine interleukin 10.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

Tolerance to the foeto-placental 'graft': ten ways to support a child for nine months

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

Pathogenesis of cutaneous lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

Cytokines and cutaneous T-cell lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

Human histocompatibility leukocyte antigen (HLA)-G molecules inhibit NKAT3 expressing natural killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

MICA triggering signal for NK cell tumor lysis is counteracted by HLA-G1-mediated inhibitory signal

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

HLA-G and its KIR ligands in cancer--another enigma yet to be solved?

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

Maturation of antigen-presenting cells is compromised in HLA-G transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

LIRs/ILTs/MIRs, inhibitory and stimulatory Ig-superfamily receptors expressed in myeloid and lymphoid cells

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

Human leukocyte antigen-G-expressing cells differently modulate the release of cytokines from mononuclear cells present in the decidua versus peripheral blood

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

HLA-G has a concentration-dependent effect on the generation of an allo-CTL response

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

Soluble HLA-G influences the release of cytokines from allogeneic peripheral blood mononuclear cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

Expression of killer inhibitory receptors on cytotoxic cells from HIV-1-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

Regulation of KIR expression in human T cells: a safety mechanism that may impair protective T-cell responses

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900024-5

7 January 2021

10.1016/S1044-579X(03)00024-5

Identifiers

DOI

1 reference

9 August 2017

1 reference